A Systematic Review of the Efficacy and Safety of a Fixed-Dose Combination of Umeclidinium and Vilanterol for the Treatment of COPD
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- New developments in the combination treatment of COPD: focus on umeclidinium/vilanterolDrug Design, Development and Therapy, 2013
- Comparison of three combined pharmacological approaches with tiotropium monotherapy in stable moderate to severe COPD: A systematic reviewPulmonary Pharmacology & Therapeutics, 2012
- The Cochrane Collaboration's tool for assessing risk of bias in randomised trialsBMJ, 2011
- Treatment of COPD: Relationships between daily dosing frequency, adherence, resource use, and costsRespiratory Medicine, 2010
- Adherence to inhaled therapy, mortality and hospital admission in COPDThorax, 2009
- Outcomes for COPD pharmacological trials: from lung function to biomarkersEuropean Respiratory Journal, 2008
- Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paperEuropean Respiratory Journal, 2004
- Measuring inconsistency in meta-analysesBMJ, 2003
- The St George's Respiratory QuestionnaireRespiratory Medicine, 1991
- The Measurement of DyspneaChest, 1984